Annual Cash & Cash Equivalents
$735.10 K
+$718.50 K+4328.31%
December 1, 2023
Summary
- As of February 8, 2025, CYTO annual cash & cash equivalents is $735.10 thousand, with the most recent change of +$718.50 thousand (+4328.31%) on December 1, 2023.
- During the last 3 years, CYTO annual cash & cash equivalents has fallen by -$12.15 million (-94.30%).
- CYTO annual cash & cash equivalents is now -98.72% below its all-time high of $57.58 million, reached on December 31, 2014.
Performance
CYTO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$65.50 K
-$518.30 K-88.78%
June 1, 2024
Summary
- As of February 8, 2025, CYTO quarterly cash and cash equivalents is $65.50 thousand, with the most recent change of -$518.30 thousand (-88.78%) on June 1, 2024.
- Over the past year, CYTO quarterly cash and cash equivalents has increased by +$10.40 thousand (+18.87%).
- CYTO quarterly cash and cash equivalents is now -99.90% below its all-time high of $65.87 million, reached on June 30, 2015.
Performance
CYTO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CYTO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4328.3% | +18.9% |
| 3 y3 years | -94.3% | +294.6% |
| 5 y5 years | -86.6% | +294.6% |
CYTO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -31.7% | +4328.3% | -93.9% | +294.6% |
| 5 y | 5-year | -94.3% | +4328.3% | -99.5% | +294.6% |
| alltime | all time | -98.7% | +4328.3% | -99.9% | +294.6% |
Altamira Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $65.50 K(-88.8%) |
| Dec 2023 | $735.10 K(+4328.3%) | $583.80 K(+959.5%) |
| Jun 2023 | - | $55.10 K(+231.9%) |
| Dec 2022 | $16.60 K(-98.5%) | $16.60 K(-95.7%) |
| Jun 2022 | - | $390.50 K(-63.7%) |
| Dec 2021 | $1.08 M(-91.6%) | $1.08 M(-88.3%) |
| Jun 2021 | - | $9.19 M(-28.7%) |
| Dec 2020 | $12.89 M(+801.7%) | $12.89 M(>+9900.0%) |
| Jun 2020 | - | $42.00 K(-97.1%) |
| Dec 2019 | $1.43 M(-73.9%) | $1.43 M(-75.9%) |
| Jun 2019 | - | $5.93 M(+8.2%) |
| Dec 2018 | $5.48 M(-64.4%) | $5.48 M(+2.2%) |
| Sep 2018 | - | $5.36 M(+20.9%) |
| Jun 2018 | - | $4.43 M(-66.6%) |
| Mar 2018 | - | $13.27 M(-13.7%) |
| Dec 2017 | $15.37 M | $15.37 M(-25.8%) |
| Sep 2017 | - | $20.72 M(-24.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $27.46 M(-18.8%) |
| Mar 2017 | - | $33.83 M(+6.2%) |
| Dec 2016 | $31.88 M(-37.3%) | $31.84 M(-18.0%) |
| Sep 2016 | - | $38.84 M(+16.1%) |
| Jun 2016 | - | $33.46 M(-22.0%) |
| Mar 2016 | - | $42.89 M(-15.6%) |
| Dec 2015 | $50.83 M(-11.7%) | $50.82 M(-10.9%) |
| Sep 2015 | - | $57.03 M(-13.4%) |
| Jun 2015 | - | $65.87 M(+28.4%) |
| Mar 2015 | - | $51.31 M(-10.9%) |
| Dec 2014 | $57.58 M(+114.1%) | $57.58 M(-11.5%) |
| Sep 2014 | - | $65.07 M(+378.1%) |
| Jun 2014 | - | $13.61 M(-34.9%) |
| Mar 2014 | - | $20.90 M(-22.3%) |
| Dec 2013 | $26.89 M(>+9900.0%) | $26.89 M |
| Dec 2012 | $70.10 K(-91.2%) | - |
| Dec 2011 | $800.50 K | - |
FAQ
- What is Altamira Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Altamira Therapeutics?
- What is Altamira Therapeutics annual cash & cash equivalents year-on-year change?
- What is Altamira Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Altamira Therapeutics?
- What is Altamira Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Altamira Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CYTO is $735.10 K
What is the all time high annual cash & cash equivalents for Altamira Therapeutics?
Altamira Therapeutics all-time high annual cash & cash equivalents is $57.58 M
What is Altamira Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CYTO annual cash & cash equivalents has changed by +$718.50 K (+4328.31%)
What is Altamira Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CYTO is $65.50 K
What is the all time high quarterly cash and cash equivalents for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly cash and cash equivalents is $65.87 M
What is Altamira Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CYTO quarterly cash and cash equivalents has changed by +$10.40 K (+18.87%)